MRNA Aug 2024 157.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 0.8000 |
| Open | N/A |
| Bid | 0.3500 |
| Ask | 0.6700 |
| Strike | 157.50 |
| Expiry date | 2024-08-02 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Barrons.comGSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday, while GSK’s American depositary receipt slipped 0.2%. Shares of Moderna a leading mRNA vaccine manufacturer, were up 0.9%.
ZacksModerna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is responsible for causing avian influenza or bird flu.
Investor's Business DailyIs Moderna Stock A Sell After Crumbling On Updated RSV Vaccine Results?
Moderna stock tumbled in late June after unveiling updated test results for its RSV vaccine. Is MRNA stock now a sell?
© 2024 Yahoo. All rights reserved.